Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note released on Saturday morning. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Trading Down 0.5 %

Shares of STRM stock opened at $3.66 on Friday. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75. The firm has a 50-day moving average price of $2.87 and a 200 day moving average price of $4.96. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $15.64 million, a P/E ratio of -0.74 and a beta of 1.67.

Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Monday, December 16th. The company reported ($0.61) EPS for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.